
APYX Reddit Mentions
Track APYX's AI-powered predictions, market trends, and investment insights.
You don't hold APYX in your mock portfolio yet.
Track APYX's AI-powered predictions, market trends, and investment insights.
You don't hold APYX in your mock portfolio yet.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get StartedThe negative EPS and resulting negative P/E ratio indicate that Apyx Medical is currently unprofitable. While the stock has risen recently, the lack of positive earnings suggests the move is not yet supported by clear underlying profitability. Without evidence of improving margins or a clear path to earnings, the financial profile remains weak.
Apyx Medical’s share price at $4.47 is trading well above its 200‑day moving average of $3.41, signaling a positive intermediate‑term trend. The 21.8% gain over the last month reflects strong recent momentum, suggesting improving investor sentiment. Technically, the stock appears to be in an uptrend, although fundamentals have not yet caught up.
Alternative data show modest but not explosive engagement with Apyx Medical’s ecosystem. Website traffic is relatively low, and hiring activity is flat with zero current job openings, which does not signal aggressive growth investment. Social media followings are small but generally trending up slowly, suggesting incremental brand awareness rather than a strong inflection.
Apyx Medical’s stock is showing bullish technical momentum, trading well above its 200‑day moving average and up sharply over the past month, but this strength is not yet supported by profitability. Alternative data are mixed, with modest online presence growth and no visible hiring expansion. Overall, the setup appears balanced: positive price action offset by weak earnings and only incremental fundamental and alternative‑data support.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Reddit discussion around Apyx Medical (APYX) remains sparse as of mid-2025, with dedicated mention data still being aggregated across major investing communities. While direct Reddit volume figures are pending, StockTwits recorded 10 mentions over the past seven days — a modest signal for a $167M small-cap medical device company. APYX, which trades on NASDAQ near $3.99, has not yet generated the kind of retail momentum typically needed to fuel sustained conversation threads on platforms like r/wallstreetbets or r/stocks.
The low social media footprint aligns with APYX's current AI Score of 5 out of 10 — a neutral reading that reflects neither strong bullish conviction nor heavy bearish pressure in the community. The stock's 3.7% single-day decline may prompt incremental attention from retail traders scanning for beaten-down small-caps, but 10 StockTwits mentions over seven days suggests limited speculative interest at this stage. Historically, a pickup in Reddit and StockTwits volume ahead of earnings or product news can act as an early-warning indicator for price volatility in thinly covered names like APYX.
TrendEdge aggregates Reddit mention volume, sentiment scores, and StockTwits activity alongside proprietary AI scoring to give investors a complete picture of retail sentiment for APYX. Rather than relying on any single data source, TrendEdge cross-references community discussion trends with price action, trading volume, and fundamental signals — enabling users to identify when social momentum is building or fading for stocks like Apyx Medical before it becomes headline news.
Unlock comprehensive alternative data signals to make better investment decisions
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Web Traffic
7,542
Twitter Followers
1,701
Instagram Followers
2,902
YouTube Subscribers
103
LinkedIn Followers
6,095
Job Postings
0
LinkedIn Employees
142
News Mentions
0
Key Metrics